Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial [version 1; referees: 2 approved]
Background: Disulfiram (DSF) is a well-tolerated, inexpensive, generic drug that has been in use to treat alcoholism since the 1950s. There is now independent preclinical data that supports DSF as an anticancer agent, and experimental data suggest that copper may increase its anti-neoplastic propert...
Main Authors: | Asgeir Store Jakola, Katja Werlenius, Munila Mudaisi, Sofia Hylin, Sara Kinhult, Jiri Bartek Jr., Øyvind Salvesen, Sven Magnus Carlsen, Michael Strandéus, Magnus Lindskog, David Löfgren, Bertil Rydenhag, Louise Carstam, Sasha Gulati, Ole Solheim, Jiri Bartek, Tora Solheim |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-11-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-1797/v1 |
Similar Items
-
Lower-Grade Gliomas: An Epidemiological Voxel-Based Analysis of Location and Proximity to Eloquent Regions
by: Tomás Gómez Vecchio, et al.
Published: (2021-09-01) -
Short-Term Surgical Outcome for Vestibular Schwannoma in Sweden: A Nation-Wide Registry Study
by: Jiri Bartek Jr., et al.
Published: (2019-01-01) -
Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study
by: Isabelle Rydén, et al.
Published: (2021-03-01) -
Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients.
by: Katja Werlenius, et al.
Published: (2020-01-01) -
Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study [version 1; referees: 2 approved]
by: Sasha Gulati, et al.
Published: (2015-12-01)